Open AccessP2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries
Author(s) -
Uwe Zeymer,
Petr Widimský,
Nicolas Danchin,
Maddalena Lettino,
Alfredo Bardajı́,
José A. Barrabés,
Ángel Cequier,
Marc J. Claeys,
Leonardo De Luca,
Jakob Dörler,
David Erlinge,
Paul Erné,
Patrick Goldstein,
Sasha Koul,
Gilles Lemesle,
Thomas F. Lüscher,
Christian M. Matter,
Gilles Montalescot,
Dragana Radovanović,
J. López Sendón,
Petr Toušek,
Franz Weidinger,
Clive Weston,
Azfar Zaman,
Pontus Andell,
Jin Li,
J. Wouter Jukema
Publication year - 2016
Publication title -
european heart journal - cardiovascular pharmacotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.895
H-Index - 26
eISSN - 2055-6845
pISSN - 2055-6837
DOI - 10.1093/ehjcvp/pvw005
Subject(s) - medicine , acute coronary syndrome , prasugrel , ticagrelor , clopidogrel , p2y12 , st elevation , emergency medicine , intensive care medicine , myocardial infarction
Non-ST-elevation acute coronary syndrome (NSTE-ACS) is present in about 60-70% of patients admitted with acute coronary syndromes in clinical practice. This study provides a 'real-life' overview of NSTE-ACS patient characteristics, dual antiplatelet therapy clinical practice, and outcomes at both the time of discharge from hospital and up to 1-year post-discharge.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom